文献速递重症综合管理与镇静镇痛

重症监护药师加入远程重症监护网络的实施与影响

Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network.
PubMed 文献 · Crit Care Explor · 2023-01-12
一句话结论在8家社区医院远程重症监护网络中增设重症监护药师,2年记录2838项干预,避免总费用1664254美元,投资回报比4.5:1。

本研究为多中心观察性队列研究,描述在美国一个25家医院(563张ICU床)的整合医疗系统中,8家社区医院(50张ICU床)的远程重症监护网络内实施重症监护药师服务的可行性。远程重症监护药师按8小时班次工作,最初每周5天,后扩展至每周7天,干预按美国卫生系统药师协会(American Society of Health-System Pharmacists)基准标准和最新成本避免数据分类。2年分析期内,远程重症监护药师记录2838项干预,产生1664254美元总成本避免,投资回报比4.5:1。作者结论认为在现有远程重症监护网络中实施远程重症监护药师是可行的,显示了对社区医院危重患者的综合照护增强并带来显著成本避免。

要点

  • 远程重症监护药师服务按8小时班次实施,最初每周5天,后扩展至每周7天。
  • 2年分析期内记录2838项干预,产生1664254美元总成本避免。
  • 投资回报比为4.5:1。
  • 研究覆盖美国一个25家医院整合医疗系统中的8家社区医院,共50张ICU床(系统总计563张ICU床)。
  • 作者认为在现有远程重症监护网络中实施远程重症监护药师是可行的。

适用人群与场景

  • 收治于美国一个25家医院整合医疗系统中8家社区医院ICU的危重成人患者,8家医院共50张ICU床,系统总计563张ICU床。

处置流程与药物剂量

  • 远程重症监护药师服务按8小时班次实施,最初每周5天,后扩展至每周7天。
  • 重症监护药师干预按美国卫生系统药师协会(American Society of Health-System Pharmacists)基准标准和最新成本避免数据分类。

研究设计与关键结果

  • 研究设计为多中心观察性队列研究及回顾性投资回报分析,时间范围为2019年12月至2021年12月。
  • 2年分析期内,远程重症监护药师记录2838项干预,产生1664254美元总成本避免,投资回报比为4.5:1。
  • 作者报告该经验显示了对大型整合医疗系统中社区医院危重患者综合照护的增强,并带来了其他举措,包括与Life Flight的临床/运营合作。

证据类型、等级与局限

  • 证据类型:多中心观察性队列研究及回顾性投资回报分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为在现有远程重症监护网络中实施远程重症监护药师是可行的,其经验显示了对社区医院危重患者综合照护的增强并带来显著成本避免。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Critical care pharmacists when incorporated into the ICU team, have been shown to improve outcomes in critically ill patients by decreasing mortality, improving morbidity and reducing cost. As telehealth continues to evolve, the incorporation of a critical care pharmacist into a comprehensive telecritical care (TCC) service will allow increased comprehensive pharmacotherapeutic care for those in smaller, community or rural hospitals.

OBJECTIVES: To describe the implementation of a TCC pharmacist into an established TCC network, classify interventions performed, and quantify cost avoidance generated through pharmacist interventions.

DESIGN: Multicenter, observational cohort study and retrospective return on investment, performed between December 2019 and December 2021.

SETTING AND PARTICIPANTS: Critically ill adult patients, admitted to an ICU located in any of our eight community hospitals (50 ICU beds) within a large, 25-hospital integrated healthcare system (563 ICU beds total) in the United States.

MAIN OUTCOMES AND MEASURES: The TCC pharmacist service was implemented in 8-hour shifts, initially available 5 days per week, then expanded to 7 days per week. Critical care pharmacist interventions were categorized by clinical type established utilizing American Society of Health-System Pharmacists benchmarking standards and the latest cost avoidance data.

RESULTS: During the 2-year analysis period, TCC pharmacists documented 2,838 interventions generating $1,664,254 of gross cost avoidance and a return on investment of 4.5:1.

CONCLUSIONS AND RELEVANCE: It is feasible to implement a TCC pharmacist within an established TCC network. Our experience showed enhanced comprehensive care of critically ill patients located in community hospitals within a large, integrated healthcare system, demonstrated significant cost avoidance, and has led to other initiatives, including a collaborative clinical/operational partnership with Life Flight.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Belcher RM, Blair A, Chauv S, et al. Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network. Crit Care Explor. 2023. PMID: 36660010. doi:10.1097/CCE.0000000000000839

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。